Investor Overview

Update
Headquarters:
Montréal
Description:
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting

Detailed Description

Update

The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies developing novel therapeutics to treat metabolic disorders (e.g. diabetes, obesity), cardiovascular diseases, cancers, diseases of the central nervous system (e.g. Alzheimer, Parkinson, insomnia), inflammatory diseases (e.g. rheumatoid arthritis, psoriasis), ophthalmic diseases and numerous other age-related diseases.

Current Team (1)

Update

Investments (12)

Update

Offices/Locations (1)

Update
  • Office

    1 Westmount Square

    Suite 800

    Montréal, H3Z 2P9

    CAN